Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Accounts Payables (2022 - 2023)

Historic Accounts Payables for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $3.8 million.

  • Therapeutics' Accounts Payables fell 551.36% to $3.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.8 million, marking a year-over-year decrease of 551.36%. This contributed to the annual value of $2.6 million for FY2022, which is N/A changed from last year.
  • Per Therapeutics' latest filing, its Accounts Payables stood at $3.8 million for Q3 2023, which was down 551.36% from $2.7 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Accounts Payables ranged from a high of $4.0 million in Q3 2022 and a low of $2.0 million during Q1 2023